Home    Back

Recifercept (proposed inn)    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
276Achondroplasia2

276. Achondroplasia    [ 37 clinical trials,   29 drugs,   (DrugBank: 6 drugs),   4 drug target genes,   25 drug target pathways]
Searched query = "Achondroplasia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 37 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2020-001189-13-DK
(EUCTR)		22/12/202007/10/2020Phase 2 study of safety, tolerability, PK and efficacy of recifercept in achondroplasiaA PHASE 2 MULTIPLE DOSE, RANDOMIZED STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF RECIFERCEPT IN CHILDREN WITH ACHONDROPLASIA Achondroplasia
MedDRA version: 20.0;Level: LLT;Classification code 10000452;Term: Achondroplasia;System Organ Class: 100000004850;Therapeutic area: Body processes [G] - Bones and nerves physological processes [G11]		Product Name: Recifercept (proposed INN)
Product Code: PF-07256472
INN or Proposed INN: Recifercept (proposed INN)
Other descriptive name: TA-46		Pfizer Inc., 235 East 42nd Street, New York, NY 10017NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes		63Phase 2Portugal;United States;Spain;Belgium;Australia;Denmark;United Kingdom;Italy;Japan
2EUCTR2020-001189-13-PT
(EUCTR)		29/09/2020Phase 2 study of safety, tolerability, PK and efficacy of recifercept in achondroplasiaA PHASE 2 MULTIPLE DOSE, RANDOMIZED STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF RECIFERCEPT IN CHILDREN WITH ACHONDROPLASIA Achondroplasia
MedDRA version: 20.0;Level: LLT;Classification code 10000452;Term: Achondroplasia;System Organ Class: 100000004850;Therapeutic area: Body processes [G] - Bones and nerves physological processes [G11]		Product Name: Recifercept (proposed INN)
Product Code: PF-07256472
INN or Proposed INN: Recifercept (proposed INN)
Other descriptive name: TA-46		Pfizer Inc.NULLNAFemale: yes
Male: yes		63Phase 2United States;Portugal;Canada;Spain;Belgium;Denmark;Australia;United Kingdom;Japan;Italy